Sg Americas Securities, LLC Neurocrine Biosciences Inc Transaction History

Sg Americas Securities, LLC

  • $30.5 Billion
  • Q1 2025

A detailed history of Sg Americas Securities, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 175,613 shares of NBIX stock, worth $23.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
175,613
Previous 1,062 16436.06%
Holding current value
$23.3 Million
Previous $145,000 13295.17%
% of portfolio
0.06%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 15, 2025
BUY
$107.22 - $153.29 $18.7 Million - $26.8 Million
174,551 Added 16436.06%
175,613 $19.4 Million
Q4 2024

Jan 17, 2025
SELL
$111.62 - $139.44 $783,795 - $979,147
-7,022 Reduced 86.86%
1,062 $145,000
Q3 2024

Oct 03, 2024
SELL
$114.58 - $153.15 $3.94 Million - $5.27 Million
-34,394 Reduced 80.97%
8,084 $931,000
Q2 2024

Jul 12, 2024
BUY
$130.86 - $143.19 $5.56 Million - $6.08 Million
42,478 New
42,478 $5.85 Million
Q4 2023

Jan 12, 2024
SELL
$106.07 - $132.76 $1.83 Million - $2.29 Million
-17,273 Reduced 70.64%
7,180 $946,000
Q3 2023

Oct 13, 2023
BUY
$94.02 - $117.1 $2.3 Million - $2.86 Million
24,453 New
24,453 $2.75 Million
Q1 2023

Apr 28, 2023
BUY
$94.11 - $123.02 $2.13 Million - $2.79 Million
22,676 Added 308.35%
30,030 $3.04 Million
Q4 2022

Feb 02, 2023
BUY
$106.72 - $127.06 $784,818 - $934,399
7,354 New
7,354 $878,000
Q2 2022

Jul 29, 2022
SELL
$75.79 - $100.07 $1.71 Million - $2.26 Million
-22,553 Reduced 52.14%
20,700 $2.02 Million
Q1 2022

Apr 29, 2022
SELL
$72.45 - $94.81 $5,506 - $7,205
-76 Reduced 0.18%
43,253 $4.06 Million
Q4 2021

Feb 07, 2022
BUY
$79.65 - $106.22 $408,684 - $545,014
5,131 Added 13.43%
43,329 $3.69 Million
Q3 2021

Nov 01, 2021
BUY
$86.18 - $99.03 $277,758 - $319,173
3,223 Added 9.22%
38,198 $3.66 Million
Q2 2021

Aug 12, 2021
SELL
$89.43 - $102.27 $1.76 Million - $2.01 Million
-19,636 Reduced 35.96%
34,975 $3.4 Million
Q1 2021

May 13, 2021
BUY
$87.57 - $119.4 $4.21 Million - $5.74 Million
48,039 Added 730.96%
54,611 $5.31 Million
Q4 2020

Feb 04, 2021
SELL
$86.91 - $108.33 $813,129 - $1.01 Million
-9,356 Reduced 58.74%
6,572 $630,000
Q3 2020

Nov 09, 2020
BUY
$96.16 - $135.15 $440,028 - $618,446
4,576 Added 40.31%
15,928 $1.53 Million
Q2 2020

Jul 20, 2020
SELL
$85.09 - $130.36 $579,803 - $888,273
-6,814 Reduced 37.51%
11,352 $1.39 Million
Q1 2020

Apr 30, 2020
BUY
$75.11 - $113.76 $1.26 Million - $1.91 Million
16,821 Added 1250.63%
18,166 $1.57 Million
Q4 2019

Jan 28, 2020
SELL
$86.8 - $118.57 $193,911 - $264,885
-2,234 Reduced 62.42%
1,345 $145,000
Q3 2019

Nov 04, 2019
SELL
$83.82 - $101.5 $118,437 - $143,419
-1,413 Reduced 28.31%
3,579 $323,000
Q2 2019

Jul 29, 2019
BUY
$72.24 - $91.27 $208,484 - $263,405
2,886 Added 137.04%
4,992 $421,000
Q1 2019

Apr 29, 2019
BUY
$69.31 - $91.53 $9,356 - $12,356
135 Added 6.85%
2,106 $186,000
Q4 2018

Feb 01, 2019
BUY
$68.32 - $124.36 $10,726 - $19,524
157 Added 8.65%
1,971 $141,000
Q3 2018

Nov 06, 2018
SELL
$98.88 - $125.85 $2.71 Million - $3.45 Million
-27,426 Reduced 93.8%
1,814 $223,000
Q2 2018

Aug 07, 2018
BUY
$75.3 - $105.99 $2.1 Million - $2.96 Million
27,904 Added 2088.62%
29,240 $2.87 Million
Q1 2018

May 03, 2018
SELL
$75.88 - $92.43 $234,620 - $285,793
-3,092 Reduced 69.83%
1,336 $111,000
Q4 2017

Jan 24, 2018
BUY
$58.53 - $77.59 $259,170 - $343,568
4,428
4,428 $344,000

Others Institutions Holding NBIX

# of Institutions
648
Shares Held
96.9M
Call Options Held
749K
Put Options Held
553K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12.7B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email